We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Tumors Require Help from Macrophages to Metastasize

By LabMedica International staff writers
Posted on 25 Aug 2009
Cancer researchers have found that metastasis relies on the cooperation of a distinct sub-population of macrophages, a link that may be broken by appropriate drug intervention.

Investigators at the Albert Einstein College of Medicine (New York, NY, USA) analyzed the movement of breast cancer cells in mice. More...
They reported in the August 10, 2009, online edition of the journal PLoS ONE that a population of host macrophages displaying a distinct phenotype was recruited by roaming pulmonary metastatic cells regardless of species of origin.

Reduction of this macrophage population through three independent means (genetic and chemical) showed that these macrophages were required for efficient metastatic seeding and growth. Importantly, even after metastatic growth was established, elimination of this macrophage population inhibited subsequent growth.

"This new study is important because it definitively shows the effects of macrophages at distant sites, as well as the identity of the macrophage population," explained senior author Dr. Jeffrey W. Pollard, professor of developmental and molecular biology at Albert Einstein College of Medicine. "This is the first proof that they have impact at this location, at the site of metastatic tumor growth."

"This suggests that antimacrophage therapy will have an impact in patients even with metastatic disease," said Dr. Pollard. "Macrophages themselves, or their unique signaling pathways, represent new therapeutic targets that may be efficacious in reducing cancer mortality."

Related Links:

Albert Einstein College of Medicine



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.